On September 26th, 2025, Neurovirtual participated in the Ohio State University Sleep Symposium 2025, a leading forum for advancing sleep medicine research and clinical practice. This year’s program focused on critical topics such as the role of GLP-1 therapies in obstructive sleep apnea, the use of wearable devices, and strategies for managing advanced PAP technologies.
Representing Neurovirtual were Angela Israel and Sergio Solis, who welcomed attendees and presented the company’s flagship solution, the BWIII PSG Plus. The BWIII amplifier is equipped with 50 channels and combines full EEG and PSG monitoring into one state-of-the-art system, making it a powerful tool for clinicians seeking accuracy, versatility, and efficiency in both sleep and neurology studies. Visiting specialists in sleep medicine including Danielle Livelsberger, Jamie Kenley, Crista Reed, and Alberta Amoakwa had the opportunity to learn more about the technology at the Neurovirtual booth.
By showcasing the BWIII PSG Plus at such a prestigious event, Neurovirtual reinforced its commitment to supporting the medical community with advanced solutions for polysomnography and sleep disorder management. The company’s presence at the Ohio State University Sleep Symposium highlighted not only its dedication to innovation but also its role in shaping the future of sleep diagnostics through education, collaboration, and cutting-edge technology.
Learn more about the event here: The Ohio State University Sleep Symposium 2025